El interés en corto de 10x Genomics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de 10x Genomics. Los datos de interés en corto se actualizan cada dos semanas.

10x Genomics (NASDAQ:TXG) Bolsa, Informe de interés en corto

10x Genomics

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

10x Genomics Inc

TEXAS GULF ENERGY INC by Texas Gulf Energy, Incorporated.

Texas Gulf Energy Inc

Meta Platforms, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), the parent company of Facebook, Instagram, and Threads, aims to advance wearable technology by integrating displays into its Ray-Ban smart glasses by 2025, the Financial Times reports.
The $300 sunglasses, developed with eyewear giant EssilorLuxottica (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ESLOF#OTC">ESLOF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ESLOY#OTC">ESLOY</a>), could feature small screens to display notifications and responses from Meta&#8217;s virtual assistant, the Financial Times <a target="_blank" href="https://www.ft.com/content/77bd9117-0a2d-4bd7-9248-4dd288f695a4" rel="noreferrer noopener">cites</a> familiar sources.
This development aims to position Meta as a frontrunner in augmented reality (AR) and wearable computing, which has the potential to replace smartphones as key computing devices.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/10/41377833/meta-cuts-jobs-in-whatsapp-instagram-and-reality-labs-in-latest-reorganization" rel="noreferrer noopener">Meta Cuts Jobs in WhatsApp, Instagram, and Reality Labs In Latest Reorganization</a>
According to the report, the next iteration of Ray-Ban Meta glasses, expected in late 2025, will introduce display technology, marking a step toward CEO Mark Zuckerberg&#8217;s vision of lightweight AR headsets.
The move aligns with Meta&#8217;s broader strategy to integrate advanced technologies into everyday wearables, <a target="_blank" href="https://www.benzinga.com/markets/equities/24/09/40699921/snap-ceo-evan-spiegel-announces-focus-on-ad-business-and-ar-amid-still-competition-from-tiktok-a" rel="noreferrer noopener">competing with companies</a> like Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>).
Meta is also fast-tracking the development of its prototype AR glasses, Orion, after receiving positive feedback from early testers. The glasses feature advanced silicon carbide lenses for brighter and larger imagery.
Last week, Meta launched <a target="_blank" href="https://www.benzinga.com/24/12/42524192/metas-ray-ban-smart-glasses-can-now-be-your-chef-linguist-and-dj-whats-next-therapist" rel="noreferrer noopener">three new features</a> for its Ray-Ban smart glasses, including live AI, live translations, and&nbsp;Shazam.
Meta&#8217;s smart glasses&nbsp;have emerged as a blockbuster product in 60% of Ray-Ban stores in <a target="_blank" href="https://www.benzinga.com/news/24/10/41458752/metas-smart-glasses-dominate-ray-ban-stores-ai-features-still-missing" rel="noreferrer noopener">Europe, the Middle East, and Africa</a>. Despite lacking AI features in Europe, the glasses outperformed conventional Ray-Ban models.
In mid-December, Meta CTO Andrew Bosworth <a target="_blank" href="https://about.fb.com/news/2024/12/accelerating-the-future-ai-mixed-reality-and-the-metaverse/" rel="noreferrer noopener">flagged 2025 as</a> the most significant year in the history of the Reality Labs unit behind the company&#8217;s glasses and headsets.
According to reports, the current model features sensitive in-ear speakers, cameras, and microphones.
Wall Street firms, including JMP Securities, Wedbush, Oppenheimer, and Guggenheim, hailed Meta&#8217;s <a target="_blank" href="https://www.benzinga.com/news/24/09/41054106/meta-analysts-highlight-ai-vr-advances-see-growth-pushing-it-toward-apple-like-valuation" rel="noreferrer noopener">launch of a VR headset</a> and AI updates after the Connect event in September. They expect Meta&#8217;s AI and VR innovations to be pivotal in helping it reach valuations like Apple&#8217;s.
Meta stock surged 71% year-to-date. Investors can gain exposure to the stock through Vanguard Large-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VV#NYSE">VV</a>) and Vanguard Communication Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOX#NYSE">VOX</a>).
Price Action: META stock is up 2.28% at $598.53 at last check Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41465662/metas-reels-monetization-and-ai-innovations-drive-top-ai-pick-analyst" target="_blank" rel="noreferrer noopener">Meta&#8217;s Reels Monetization and AI Innovations Drive Top AI Pick: Analyst</a></li>
</ul>
Photo via Shutterstock

News

Tech

Media

AAPL

ESLOF

ESLOY

GOOGL

MSFT

SNAP

Meta Plans Display-Equipped Ray-Ban Glasses By 2025: FT

Billionaire Stanley Druckenmiller, a George Soros protégé, is known for his &#8220;top-down&#8221; investing style. Druckenmiller&#8217;s strategy focuses on <a href="https://www.benzinga.com/general/health-care/24/12/42627207/stanley-druckenmillers-top-holding-has-outperformed-its-sector-by-252" target="_blank" rel="noopener">making large bets</a> on macroeconomic trends, prioritizing top-performing industries over individual companies.
The Bowdoin College and University of Michigan alumnus recently upped his stake in Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), a $1 trillion semiconductor company based in San Jose, California.
Druckenmiller closed his hedge fund, Duquesne Capital in 2010, but still maintains the Duquesne Family Office to manage his wealth.
Druckenmiller first bought 51,956 shares in the company in mid-to-late 2023, selling all before the next quarter. The latest Duquesne 13F filing, revealing the firm&#8217;s holdings as of Sept. 30, showed Druckenmiller upping his wager on Broadcom to 239,980 shares. The investment — up over 35% since September — represents a market value of almost $56 million, one of his largest holdings.
Shares of the company were already trading up over 100% between his first filing and the latest filing.
Also Read: <a href="https://www.benzinga.com/24/12/42653753/history-may-hint-at-sp-500-struggles-in-2025-yet-there-is-also-hope-heres-why">History Suggests S&amp;P 500 Could Struggle In 2025, But There&#8217;s Reason For Optimism</a>
Druckenmiller previously called NVIDIA Corp&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) ascension, buying shares in late 2022 and early 2023, but sold off most of his position before the company&#8217;s historic rally in 2024. The investor <a href="https://www.benzinga.com/markets/equities/24/10/41374232/amid-nvidias-stratospheric-rally-billionaire-investor-druckenmiller-regrets-cashing-out-of-ai-st">later called the sale</a> a &#8220;big mistake.&#8221;
Broadcom is a global technology company that designs, develops, and supplies semiconductor and infrastructure software solutions. Its products, which include chips for networking, broadband, wireless communications, and storage, as well as enterprise software for cybersecurity and data management, power a wide range of industries, from telecommunications and data centers to consumer electronics.
The company&#8217;s shares were trading almost 5% higher at the time of publication Monday following news that the U.S. is opening an investigation into China&#8217;s semiconductor industry policies, according to <a href="https://www.benzinga.com/pro/" target="_blank" rel="noopener">Benzinga Pro</a>.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42656254/tech-stocks-eye-christmas-gains-microstrategy-tumbles-as-bitcoin-dips-to-93000-whats-driving-markets-monday">Tech Stocks Eye Christmas Gains, Microstrategy Tumbles As Bitcoin Dips To $93,000: What&#8217;s Driving Markets Monday?</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

Large Cap

Hedge Funds

Trading Ideas

AVGO

NVDA

Druckenmiller Bets Big On Semiconductor Stock Just Before It Spikes To $1 Trillion

High-rolling investors have positioned themselves bullish on BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in BLK often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 10 options trades for BlackRock. This is not a typical pattern.
The sentiment among these major traders is split, with 40% bullish and 30% bearish. Among all the options we identified, there was one put, amounting to $90,100, and 9 calls, totaling $380,745.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $600.0 to $1120.0 for BlackRock over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for BlackRock's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across BlackRock's significant trades, within a strike price range of $600.0 to $1120.0, over the past month.
<h3>BlackRock Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734985834_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BLK</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$96.0</td>
<td>$87.9</td>
<td>$90.1</td>
<td>$980.00</td>
<td>$90.1K</td>
<td align="right">9</td>
<td align="right">0</td>
</tr>
<tr>
<td>BLK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$65.5</td>
<td>$58.7</td>
<td>$61.0</td>
<td>$1020.00</td>
<td>$61.0K</td>
<td align="right">89</td>
<td align="right">10</td>
</tr>
<tr>
<td>BLK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$81.2</td>
<td>$77.9</td>
<td>$81.2</td>
<td>$1120.00</td>
<td>$56.8K</td>
<td align="right">5</td>
<td align="right">7</td>
</tr>
<tr>
<td>BLK</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$79.4</td>
<td>$75.6</td>
<td>$77.5</td>
<td>$970.00</td>
<td>$54.2K</td>
<td align="right">119</td>
<td align="right">7</td>
</tr>
<tr>
<td>BLK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$39.1</td>
<td>$38.2</td>
<td>$39.1</td>
<td>$1020.00</td>
<td>$46.9K</td>
<td align="right">217</td>
<td align="right">13</td>
</tr>
</tbody>
</table>

<h3>About BlackRock</h3>
BlackRock is the largest asset manager in the world, with $11.475 trillion in assets under management at the end of September 2024. Its product mix is fairly diverse, with 55% of managed assets in equity strategies, 26% in fixed income, 9% in multi-asset classes, 7% in money market funds, and 3% in alternatives. Passive strategies account for around two thirds of long-term AUM, with the company's ETF platform maintaining a leading market share domestically and on a global basis. Product distribution is weighted more toward institutional clients, which by our calculations account for around 80% of AUM. BlackRock is geographically diverse, with clients in more than 100 countries and more than one third of managed assets coming from investors domiciled outside the US and Canada.
Having examined the options trading patterns of BlackRock, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of BlackRock</h3>
<ul>
<li>With a trading volume of 261,854, the price of BLK is up by 0.84%, reaching $1037.37.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 18 days from now.</li>
</ul>
<h3>What Analysts Are Saying About BlackRock</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $1227.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for BlackRock, targeting a price of $1220. 
&#x2A; An analyst from Citigroup persists with their Buy rating on BlackRock, maintaining a target price of $1200. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on BlackRock, which currently sits at a price target of $1261. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest BlackRock options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

BlackRock Unusual Options Activity For December 23

Financial giants have made a conspicuous bearish move on Micron Technology. Our analysis of options history for Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) revealed 81 unusual trades.
Delving into the details, we found 37% of traders were bullish, while 48% showed bearish tendencies. Out of all the trades we spotted, 40 were puts, with a value of $2,965,115, and 41 were calls, valued at $4,609,560.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $50.0 to $220.0 for Micron Technology over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Micron Technology's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Micron Technology's significant trades, within a strike price range of $50.0 to $220.0, over the past month.
<h3>Micron Technology Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734985829_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$5.85</td>
<td>$5.7</td>
<td>$5.8</td>
<td>$70.00</td>
<td>$725.0K</td>
<td>977</td>
<td>1.2K</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.45</td>
<td>$6.4</td>
<td>$6.5</td>
<td>$105.00</td>
<td>$381.6K</td>
<td>5.0K</td>
<td>615</td>
</tr>
<tr>
<td>MU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$6.25</td>
<td>$6.15</td>
<td>$6.25</td>
<td>$80.00</td>
<td>$368.4K</td>
<td>5.2K</td>
<td>610</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$6.4</td>
<td>$6.35</td>
<td>$6.4</td>
<td>$105.00</td>
<td>$361.0K</td>
<td>5.0K</td>
<td>1.2K</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$17.95</td>
<td>$17.85</td>
<td>$17.85</td>
<td>$90.00</td>
<td>$239.2K</td>
<td>934</td>
<td>264</td>
</tr>
</tbody>
</table>

<h3>About Micron Technology</h3>
Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.
After a thorough review of the options trading surrounding Micron Technology, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Micron Technology</h3>
<ul>
<li>With a trading volume of 17,500,834, the price of MU is down by -0.62%, reaching $89.56.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 86 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Micron Technology</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $146.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Rosenblatt has decided to maintain their Buy rating on Micron Technology, which currently sits at a price target of $250. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Micron Technology, targeting a price of $110. 
&#x2A; Maintaining their stance, an analyst from Needham continues to hold a Buy rating for Micron Technology, targeting a price of $120. 
&#x2A; Consistent in their evaluation, an analyst from Wedbush keeps a Outperform rating on Micron Technology with a target price of $125. 
&#x2A; An analyst from TD Cowen persists with their Buy rating on Micron Technology, maintaining a target price of $125. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Micron Technology, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Smart Money Is Betting Big In Micron Technology Options

Whales with a lot of money to spend have taken a noticeably bearish stance on MARA Holdings.
Looking at options history for MARA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) we detected 43 trades.
If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 55% with bearish.
From the overall spotted trades, 24 are puts, for a total amount of $1,658,642 and 19, calls, for a total amount of $946,324.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $8.0 and $35.0 for MARA Holdings, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for MARA Holdings's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of MARA Holdings's whale activity within a strike price range from $8.0 to $35.0 in the last 30 days. 
<h3>MARA Holdings Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734985823_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.67</td>
<td>$1.62</td>
<td>$1.67</td>
<td>$8.00</td>
<td>$417.5K</td>
<td>3.3K</td>
<td>2.7K</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$8.4</td>
<td>$8.3</td>
<td>$8.3</td>
<td>$26.00</td>
<td>$166.0K</td>
<td>94</td>
<td>0</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$8.25</td>
<td>$8.2</td>
<td>$8.25</td>
<td>$20.00</td>
<td>$115.5K</td>
<td>5.2K</td>
<td>162</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$2.88</td>
<td>$2.82</td>
<td>$2.83</td>
<td>$24.00</td>
<td>$112.4K</td>
<td>4.0K</td>
<td>550</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$5.25</td>
<td>$4.8</td>
<td>$5.05</td>
<td>$15.00</td>
<td>$101.0K</td>
<td>8.2K</td>
<td>200</td>
</tr>
</tbody>
</table>

<h3>About MARA Holdings</h3>
MARA Holdings Inc leverages digital asset compute to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value.
Following our analysis of the options activities associated with MARA Holdings, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of MARA Holdings</h3>
<ul>
<li>With a volume of 23,955,499, the price of MARA is down -3.43% at $19.27. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 65 days.</li>
</ul>
<h3>What Analysts Are Saying About MARA Holdings</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $27.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Piper Sandler downgraded its rating to Overweight, setting a price target of $34. 
&#x2A; In a cautious move, an analyst from Barclays downgraded its rating to Equal-Weight, setting a price target of $27. 
&#x2A; An analyst from HC Wainwright &amp; Co. downgraded its action to Buy with a price target of $28. 
&#x2A; An analyst from JP Morgan has elevated its stance to Neutral, setting a new price target at $23. 
&#x2A; Consistent in their evaluation, an analyst from B. Riley Securities keeps a Neutral rating on MARA Holdings with a target price of $23. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for MARA Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

MARA

Smart Money Is Betting Big In MARA Options

We've all heard about "the 1%," but what does joining their ranks take? Spoiler: it's not pocket change.&nbsp;
According to Kiplinger data, to be in the top 1% of wealth in the U.S. in 2024, one must have a net worth of about $11.6 million. That's up significantly from past years, showing just how concentrated wealth has become at the top.
But the 1% isn't the only benchmark worth considering. The wealth ladder has plenty of rungs and the numbers may surprise you. Whether aiming to <a href="https://www.benzinga.com/personal-finance/24/12/42350109/are-you-earning-enough-to-be-considered-rich-heres-what-the-top-5-are-raking-in-annually">hit the top 10%, 5% or even 2%</a>, understanding the breakdown can be a powerful motivator – or a reality check.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
How Wealth Breaks Down by Percentile
Here's what it takes to land in different wealth brackets in the U.S.:
• Top 1%: $11.6 million
• Top 2%: $2.7 million
• Top 5%: $1.17 million
• Top 10%: $970,900
• Top 50%: $585,000
The numbers vary slightly depending on the source, but they all tell the same story: moving up the wealth ranks is no small feat. For instance, some estimates peg the 1% threshold even higher at $13.6 million.
See Also: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a>
What the Wealthy Do Differently
If you're wondering how the ultrarich get and stay wealthy, their asset allocation offers some clues. High net worth individuals (HNWIs) don't just stash their cash under the mattress. They invest – and they diversify.
Real Estate: A Cornerstone of Wealth
<a href="https://www.benzinga.com/personal-finance/24/11/41726342/can-you-guess-what-asset-the-ultra-wealthy-invest-in-most-heres-a-hint-its-not-stocks">Real estate is a big deal</a> for the wealthy. According to Knight Frank, the ultra-wealthy allocate about 32% of their wealth to residential properties and 21% to commercial real estate. Why? Because real estate has a track record of steady appreciation and can weather market volatility better than many other investments.
Even if you're not in the market for a multimillion-dollar mansion, owning property – your home or a rental – can be a key step toward building wealth.
Stocks, Bonds and Beyond
For those with more than $3 million in investable assets, here's the average breakdown of their portfolios as reported by Financial Samurai:
• 55% in stocks
• 21% in bonds
• 15% in cash
• 6% in alternatives (like private equity or hedge funds)
• 4% in other assets
The takeaway? The wealthiest Americans spread their money across different asset classes, balancing high-risk, high-reward investments with stable ones.
Trending: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
Strategies to Grow Your Net Worth
You might not be aiming for the top 1%, but building wealth is a goal almost anyone can work toward. Here's how:
1. Invest in Real Estate: Consider owning property, even if it's your primary residence.
2. Diversify Your Portfolio: Don't <a href="https://www.benzinga.com/personal-finance/24/06/39360926/diversification-thats-for-idiots-mark-cuban-slams-warren-buffetts-investment-strategy-i-think-bu">put all your eggs in one basket – </a>stocks, bonds and other investments each have a role.
3. Think Long-Term: Slow and steady often wins the race. Focus on consistent growth rather than chasing quick wins.
4. Increase Your Income: Earning more, whether through a side hustle or career advancement, gives you more to save and invest.
5. Spend Less Than You Earn: It's not flashy, but living below your means is one of the most effective ways to build wealth.
Building wealth isn't an overnight process, but understanding the numbers and strategies that the ultra-wealthy use can be a solid first step. Whether you're just starting or climbing the wealth ladder, remember that every dollar saved and invested gets you <a href="https://www.benzinga.com/money/are-you-rich">closer to your financial goals</a>.
Read Next:
<ul>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>

Personal Finance

Does Your Net Worth Make You Rich? Here's What It Really Takes To Be In The Top 1%

O'Reilly Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) has outperformed the market over the past 15 years by 14.15% on an annualized basis producing an average annual return of 25.87%. Currently, O'Reilly Automotive has a market capitalization of $71.30 billion. 
Buying $100 In ORLY: If an investor had bought $100 of ORLY stock 15 years ago, it would be worth $3,150.53 today based on a price of $1235.10 for ORLY at the time of writing.
<h3>O'Reilly Automotive's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734985809_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ORLY

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

SLGL

Sol-Gel Technologies Shares Resume Trade Then Halted On Circuit Breaker To The Upside, Stock Now Up 224%

Following the COVID-19 pandemic,<a href="https://fred.stlouisfed.org/series/ACTLISCOUUS"> </a>active <a href="https://fred.stlouisfed.org/series/ACTLISCOUUS">listings</a> for single-family homes fell conspicuously due to public health concerns and mandated stay-in-place orders. Naturally, this framework sparked a demand bottleneck, cynically benefiting homebuilders as society gradually normalized. However, incoming political shifts could present concerns for the broader housing market.
Specifically, President-elect Donald Trump throughout the campaign trail for the 2024 election<a href="https://www.benzinga.com/news/24/10/41301544/trump-steps-up-anti-immigrant-rhetoric-proposes-nationwide-plan-to-target-venezuelan-gang-members"> broadcasted anti-immigration sentiments</a>. Combined with his<a href="https://www.benzinga.com/markets/24/12/42572520/2025-housing-market-looks-like-a-year-of-struggle-for-states-like-builders-now-hold-record-inventory"> proposed tariffs on building materials</a>, Trump's policies could drive construction costs higher. Potentially, such a development could negatively impact demand as<a href="https://www.benzinga.com/personal-finance/24/11/41728751/even-as-inflation-cools-most-americans-cant-get-ahead-and-continue-living-paycheck-to-paycheck-r"> most Americans have struggled</a> to get ahead of the paycheck-to-paycheck cycle.
Still, it's not all doom and gloom. Despite historically high mortgage rates, several Sun Belt cities may be poised for<a href="https://www.benzinga.com/markets/24/12/42515226/2025s-top-housing-markets-where-home-sales-will-jump-by-up-to-27-according-to-report"> explosive sales growth in 2025</a>, according to projections from sites like Realtor.com. Several cities in Texas have consistently placed in the top rankings regarding housing demand. Further, booming areas such as Miami, Virginia Beach, Richmond and Charlotte may reignite currently deflated sentiment for homebuilding stocks.
The Direxion ETF: For investors that view the glass as half-full, the Direxion Daily Homebuilders &amp; Supplies Bull 3X Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NAIL#NYSE">NAIL</a>) offer the ultimate in speculation. A leveraged exchange-traded fund, NAIL seeks a return that is 300% of the performance of the Dow Jones U.S. Select Home Construction Index.
Fundamentally, one of the benefits of a 3X-leveraged fund is convenience. Typically, traders seeking to magnify their returns over a short time period use options, which introduce complexities. In contrast, investors can buy units of the NAIL ETF, much like buying shares of a publicly traded company. Further, NAIL covers a basket of securities, including names like DR Horton Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) and Lennar Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>).
However, as a 3X-leveraged ETF, NAIL carries significant volatility risks. Notably, Direxion states that the fund should not be expected to provide three times the benchmark index's cumulative return for periods greater than a day. That's because exposure lasting longer than a day may expose the trader to valuation decay due to the effects of daily compounding.
Nevertheless, weekly returns of the NAIL fund over the trailing five years reflects an upward bias. Of the past 261 weeks, 146 weeks saw a positive return, reflecting a success ratio of 55.94%. What's more, there have been 12 weeks (not including last week) where NAIL lost 20% of value or more. Of this dataset, eight of the following weeks generated positive returns, with an average performance of 25.55% up.
Interestingly, in the business week ending Dec. 20, the 3X bull fund lost 21.66% of value.
The NAIL ETF: Although the leveraged housing fund was looking strong up until late November, economic and political uncertainties saw the ETF go negative for the year.
<ul>
<li>At the moment, the technical backdrop isn't enticing, with NAIL falling through its 50- and 200-day moving averages in late November and early December, respectively.</li>
<li>On the positive side, NAIL is trading above the critical $80 level, which previously acted as support throughout 2021.</li>
<li>Moving forward, it's imperative that the bulls establish a baseline of support here. This seems credible given the aforementioned upward bias, especially following a severe weekly correction.</li>
</ul>
<figure class="wp-block-image"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXdEFM2RzXULOsvKwMUJR6tMs6ytAI-exasr_VGMzxHO5iVbwfTg6kgxBTEaZbQkWqN8AogDbSPp7vu9oG_-EKHhZr5TCd7t1edl0-YXj--p31OIBfOIMvGpaFY0GVkSmDun7K4YIA?key=35wYDvIj__9IZuzPJz-CvttV" alt="" /></figure>
Featured image by <a href="https://pixabay.com/users/oleksandrpidvalnyi-4638469/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=6688945">Oleksandr Pidvalnyi</a> from <a href="https://pixabay.com/photos/real-estate-homeownership-homebuying-6688945/">Pixabay</a>.

Long Ideas

Short Ideas

Technicals

ETFs

NAIL

Investors Following Housing Sentiment May Consider Direxion's NAIL ETF

Nordstrom, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) shares are trading lower. The company on Monday announced that the Nordstrom Family and Liverpool will acquire <a href="https://www.benzinga.com/pressreleases/24/12/n42646178/nordstrom-to-be-acquired-by-nordstrom-family-and-liverpool">all outstanding common shares of Nordstrom</a>. 
What To Know: Nordstrom said it signed a definitive agreement under which Erik, Pete, Jamie, other members of the Nordstrom family and Liverpool will acquire all shares not already owned by the parties in an all-cash transaction valued at approximately $6.25 billion on an enterprise basis. 
Under terms of the agreement, Nordstrom shareholders will receive $24.25 per share in cash, representing a premium of approximately 42% over the company&#8217;s share price as of March 18. Nordstrom said March 18 was the last day its stock traded unaffected by media speculation. 
The deal will also include a special dividend of up to 25 cents per share contingent on the transaction&#8217;s closing. The acquisition will result in Nordstrom becoming a private company. Following the close, the Nordstrom Family will own 50.1% of the company, with Liverpool holding 49.9%.
The Nordstrom Board has unanimously approved the proposed transaction upon the unanimous recommendation of a special committee of independent and disinterested directors that led the review and negotiation of this transaction. 
&#8220;Following a rigorous and independent evaluation and consultation with outside financial and legal advisors, the special committee unanimously concluded that this transaction offers greater value for all public shareholders at a significant premium to the unaffected share price,&#8221; said Eric Sprunk, chairman of the special committee.
JWN Price Action: Nordstrom shares were down 1.55% at $24.15 at the time of publication Monday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23141740/Screenshot-2024-12-23-at-2.16.45%E2%80%AFPM-1024x514.png" alt="" class="wp-image-704803" style="width:535px;height:auto" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42657620/amd-and-micron-top-analyst-picks-for-ai-and-next-gen-tech-growth">AMD and Micron Are Top Analyst Picks for AI and Next-Gen Tech Growth</a></li>
</ul>
Photo: Shutterstock.

Movers

What's Going On With Nordstrom Stock Today?

EDBL

Edible Garden Enters Agreement With A Single Institutional Investor That Is An Existing Holder Of Its Warrants Wherein The Investor Agreed To Exercise 8.33M Outstanding Class B Warrants To Purchase An Aggregate Of 8.33M Shares Of Common Stock For Cash At The Exercise Price Of $0.36 Per Share, Yielding Net Proceeds Of $2.8M

Whales with a lot of money to spend have taken a noticeably bullish stance on Morgan Stanley.
Looking at options history for Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) we detected 18 trades.
If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 38% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $634,556 and 11, calls, for a total amount of $1,095,960.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $85.0 and $165.0 for Morgan Stanley, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Morgan Stanley's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Morgan Stanley's substantial trades, within a strike price spectrum from $85.0 to $165.0 over the preceding 30 days.
<h3>Morgan Stanley 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734984933_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$14.45</td>
<td>$14.3</td>
<td>$14.45</td>
<td>$125.00</td>
<td>$410.3K</td>
<td>236</td>
<td align="right">296</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$10.9</td>
<td>$10.7</td>
<td>$10.78</td>
<td>$120.00</td>
<td>$323.4K</td>
<td>70</td>
<td align="right">300</td>
</tr>
<tr>
<td>MS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.6</td>
<td>$3.6</td>
<td>$3.6</td>
<td>$125.00</td>
<td>$216.0K</td>
<td>5.6K</td>
<td align="right">635</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$3.35</td>
<td>$3.25</td>
<td>$3.3</td>
<td>$115.00</td>
<td>$82.5K</td>
<td>901</td>
<td align="right">250</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$4.4</td>
<td>$4.3</td>
<td>$4.3</td>
<td>$100.00</td>
<td>$79.9K</td>
<td>1.4K</td>
<td align="right">187</td>
</tr>
</tbody>
</table>

<h3>About Morgan Stanley</h3>
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.
After a thorough review of the options trading surrounding Morgan Stanley, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Morgan Stanley's Current Market Status</h3>
<ul>
<li>With a volume of 1,743,969, the price of MS is up 0.61% at $124.19. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 24 days.</li>
</ul>
<h3>Expert Opinions on Morgan Stanley</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $127.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Citigroup persists with their Neutral rating on Morgan Stanley, maintaining a target price of $135. 
&#x2A; An analyst from HSBC has revised its rating downward to Hold, adjusting the price target to $131. 
&#x2A; An analyst from Keefe, Bruyette &amp; Woods has decided to maintain their Market Perform rating on Morgan Stanley, which currently sits at a price target of $138. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Neutral rating for Morgan Stanley, targeting a price of $104. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Morgan Stanley with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Morgan Stanley's Options: A Look at What the Big Money is Thinking

Investors with a lot of money to spend have taken a bearish stance on Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with DOW, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 9 options trades for Dow.
This isn't normal.
The overall sentiment of these big-money traders is split between 11% bullish and 88%, bearish.
Out of all of the options we uncovered, 8 are puts, for a total amount of $743,378, and there was 1 call, for a total amount of $283,023.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $45.0 to $50.0 for Dow over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Dow options trades today is 3337.2 with a total volume of 8,234.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Dow's big money trades within a strike price range of $45.0 to $50.0 over the last 30 days.
<h3>Dow Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734984928_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$0.45</td>
<td>$0.39</td>
<td>$0.41</td>
<td>$45.00</td>
<td>$283.0K</td>
<td>953</td>
<td>6.9K</td>
</tr>
<tr>
<td>DOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$10.95</td>
<td>$10.9</td>
<td>$10.95</td>
<td>$50.00</td>
<td>$257.3K</td>
<td>2.9K</td>
<td>470</td>
</tr>
<tr>
<td>DOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$11.0</td>
<td>$10.9</td>
<td>$11.0</td>
<td>$50.00</td>
<td>$183.7K</td>
<td>2.9K</td>
<td>3</td>
</tr>
<tr>
<td>DOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$10.95</td>
<td>$10.85</td>
<td>$10.95</td>
<td>$50.00</td>
<td>$67.8K</td>
<td>2.9K</td>
<td>233</td>
</tr>
<tr>
<td>DOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$8.1</td>
<td>$8.0</td>
<td>$8.1</td>
<td>$45.00</td>
<td>$59.1K</td>
<td>1.9K</td>
<td>147</td>
</tr>
</tbody>
</table>

<h3>About Dow</h3>
Dow Chemical is a diversified global chemicals producer, formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in both consumer and industrial end markets.
After a thorough review of the options trading surrounding Dow, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Dow</h3>
<ul>
<li>With a volume of 4,189,600, the price of DOW is down -0.29% at $39.83. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 38 days.</li>
</ul>
<h3>What The Experts Say On Dow</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $48.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from RBC Capital persists with their Sector Perform rating on Dow, maintaining a target price of $44. 
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Dow, targeting a price of $47. 
&#x2A; An analyst from Citigroup persists with their Neutral rating on Dow, maintaining a target price of $41. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Dow, which currently sits at a price target of $55. 
&#x2A; In a positive move, an analyst from Evercore ISI Group has upgraded their rating to Outperform and adjusted the price target to $56. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Dow, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Market Whales and Their Recent Bets on DOW Options

Investors with a lot of money to spend have taken a bearish stance on Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NET, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Cloudflare.
This isn't normal.
The overall sentiment of these big-money traders is split between 37% bullish and 62%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $123,510, and 5 are calls, for a total amount of $318,897.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $80.0 to $155.0 for Cloudflare during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Cloudflare stands at 164.86, with a total volume reaching 615.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Cloudflare, situated within the strike price corridor from $80.0 to $155.0, throughout the last 30 days.
<h3>Cloudflare Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734984923_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$10.2</td>
<td>$10.15</td>
<td>$10.15</td>
<td>$155.00</td>
<td>$153.7K</td>
<td align="right">13</td>
<td align="right">146</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$24.35</td>
<td>$24.1</td>
<td>$24.33</td>
<td>$90.00</td>
<td>$60.8K</td>
<td align="right">229</td>
<td align="right">30</td>
</tr>
<tr>
<td>NET</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4.35</td>
<td>$4.3</td>
<td>$4.35</td>
<td>$112.00</td>
<td>$56.5K</td>
<td align="right">0</td>
<td align="right">131</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.85</td>
<td>$3.8</td>
<td>$3.85</td>
<td>$114.00</td>
<td>$38.5K</td>
<td align="right">0</td>
<td align="right">131</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$42.65</td>
<td>$41.8</td>
<td>$41.8</td>
<td>$80.00</td>
<td>$37.6K</td>
<td align="right">159</td>
<td align="right">9</td>
</tr>
</tbody>
</table>

<h3>About Cloudflare</h3>
Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.
Following our analysis of the options activities associated with Cloudflare, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Cloudflare</h3>
<ul>
<li>With a trading volume of 981,147, the price of NET is down by -1.05%, reaching $111.5.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 45 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Cloudflare</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $129.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Morgan Stanley upgraded its action to Overweight with a price target of $130. 
&#x2A; An analyst from Jefferies has decided to maintain their Hold rating on Cloudflare, which currently sits at a price target of $125. 
&#x2A; An analyst from Mizuho has decided to maintain their Neutral rating on Cloudflare, which currently sits at a price target of $125. 
&#x2A; An analyst from Stifel has elevated its stance to Buy, setting a new price target at $136. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cloudflare options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Decoding Cloudflare's Options Activity: What's the Big Picture?

Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) has outperformed the market over the past 5 years by 32.99% on an annualized basis producing an average annual return of 45.92%. Currently, Sprouts Farmers Market has a market capitalization of $12.93 billion. 
Buying $100 In SFM: If an investor had bought $100 of SFM stock 5 years ago, it would be worth $654.85 today based on a price of $129.31 for SFM at the time of writing.
<h3>Sprouts Farmers Market's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734984916_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Sprouts Farmers Market 5 Years Ago Would Be Worth Today

Sol-Gel Technologies Shares Resume Trade Then Again Halted, This Time To The Downside, Stock Now Up 126.1%

Singapore-based Davis Commodities Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTCK#NASDAQ">DTCK</a>) (the "Company" or "Davis Commodities"), has recently finalized a significant financial agreement, entering into a S$10,000,000 banking facility to fortify its operational capacities and propel strategic expansion efforts. This substantial facility stands as a part of foundation in supporting the Company's strategic expansion endeavors. With a well-structured financial framework in place, Davis Commodities is poised to leverage these allocated funds effectively, driving growth, and enhancing operational efficiency in the competitive landscape of commodity trading and financing.
To achieve greater profitability through our current resources and the bank facility requires a carefully crafted strategy customized to a company's unique operations, industry landscape, and risk appetite. Davis Commodities have set several strategic directions to stimulate growth and enhance financial outcomes.
Working Capital Optimization
One key avenue for optimizing the bank facility is through working capital management. By strategically allocating funds towards inventory purchases of high-margin, Davis Commodities can unlock significant value:
<ul>
<li>Negotiating bulk discounts with suppliers for large volume deals.</li>
<li>Enhancing cash flow by swiftly turning over inventories, thereby boosting revenue.</li>
</ul>
Expand Trade Credit
Extending trade credit to reliable customers and offering financing terms for larger orders can significantly boost sales volume and margins:
<ul>
<li>Providing short-term credit to customers.</li>
<li>Charging a small financing fee to enhance profitability.</li>
</ul>
Invest in Supply Chain Efficiencies
Investing in supply chain improvements is crucial for cost reduction and enhanced operational efficiency:
<ul>
<li>Allocating funds to streamline logistics operations and reduce delivery costs.</li>
<li>Establishing partnerships with shipping companies to secure lower rates and improve profit margins.</li>
</ul>
Hedging &amp; Arbitrage Opportunities
Another strategy involves capitalizing on price differentials in various markets through hedging and arbitrage:
<ul>
<li>Using funds to hedge against price fluctuations using futures contracts or options.</li>
<li>Exploiting price differentials by purchasing commodities in markets with lower prices and selling in regions with higher demand.</li>
</ul>
Leverage Financing for Higher ROI Projects
Identifying high-yield investment opportunities and utilizing debt responsibly to fund growth initiatives can drive substantial returns:
<ul>
<li>Investing in projects with good potential returns.</li>
<li>Ensuring that financing costs are covered by profit margins.</li>
</ul>
By effectively hedging positions and leveraging market disparities, Davis Commodities can secure profit margins and optimize returns on investments.
Secure Strategic Partnerships
By utilizing the bank facility as collateral and engaging in strategic partnerships, Davis Commodities can enhance its market position and product offerings through the following strategies:
<ul>
<li>Establishing joint ventures with suppliers or buyers.</li>
<li>Co-investing in commodity processing to improve margins and product value.</li>
</ul>
By implementing these strategic initiatives effectively, Davis Commodities can leverage its current resources and the bank facility to generate consistent profits, scale operations sustainably, and fortify its competitive edge in the dynamic commodity trading landscape.

Financing

Global

DTCK

Davis Commodities Secures S$10 Million Banking Facility To Fortify Its Operational Capacities And Propel Strategic Expansion Efforts

Sol-Gel Technologies Shares Halted On Circuit Breaker To The Upside, Stock Now Up 137.8%

WIIM

WISA

WiSA Technologies shares are trading higher after the company announced it received stockholder approval to purchase the Datavault intellectual property and information technology assets of privately held Data Vault Holdings.

Here's how we look at 2025 priorities:
<ul>
<li>First, we're laser focused on moving ahead with the potential acquisition anchored by the LOI. The next step is a definitive agreement to acquire that business.</li>
<li>We'll continue to market, distribute, install and sell both CLMBR and FORME to businesses and consumers worldwide continuing on the path we have demonstrated in Q3 and guided in Q4</li>
<li>We also expect to further strengthen our balance sheet to reinforce our ability to execute scaled M&amp;A more opportunistically.</li>
<li>We are already discussing additional, scaled acquisitions beyond the announced LOI, and will continue to identify and conduct due diligence on such opportunities.
<ul>
<li>We'll also continue to ramp up and improve our direct communications with all of our shareholders – everyone should sign up for direct emails from us; contact us; and visit not just our news page, but also <a href="https://interactivestrength.com/insights/">our new Insights page</a> – where we'll offer commentary on both TRNR and our markets.</li>
</ul>
</li>
</ul>

Guidance

TRNR

Interactive Strength Shares 2025 Priorities, To Focus On Potential Acquisition, CLMBR And FORME Global Marketing Continuation, Balance Sheet Strengthening For Scaled M&A, Additional Acquisition Discussions Beyond LOI

10X Genomics (TXG) has disclosed a new risk, in the Environmental / Social category. In a noteworthy development for 10X Genomics, CEO Serge Saxono...

10X Genomics CEO Serge Saxonov Initiates Rule 10b5-1 Trading Plan Amid Strategic Financial Maneuvering

10x Genomics (TXG) and French TechBio startup Cure51 announced that Cure51 will deploy 10x Genomics' Visium HD as part of its pioneering work to un...

10x Genomics' Visium HD selected by TechBio startup Cure51

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol-Myers Squibb (BMY – Research Report), 10x Genomics (TXG –...

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), 10x Genomics (TXG) and Bicycle Therapeutics (BCYC)

Barclays analyst Luke Sergott lowered the firm's price target on 10x Genomics (TXG) to $19 from $21 and keeps an Overweight rating on the shares. T...

10x Genomics price target lowered to $19 from $21 at Barclays

ARKK's holdings ranked by SA Quant Grades

Life sciences stocks viewed positively at TD Cowen despite post-election weakness

With vast potential, contribution to rare disease discovery and management, and adoption of AI, the genomic research market is thriving. Hence, fundamentally solid genomic research stocks Agilent Technologies (A), Illumina (ILMN), and 10x Genomics (TXG) could be ideal buys. Read more... The rising risks towards human health are pushing the research and innovations in the genomic market, opening multi-faceted opportunities for the market. Also, the rapid adoption of technological advancements is increasingly accelerating its potential to cater to patients.
Against this backdrop, it could be wise to invest in fundamentally strong genomic research stocks Agilent Technologies, Inc. (<a href="https://stocknews.com/stock/A/">A</a>), Illumina, Inc. (<a href="https://stocknews.com/stock/ILMN/">ILMN</a>), and 10x Genomics, Inc. (<a href="https://stocknews.com/stock/TXG/">TXG</a>) with significant growth potential.
Genomics is revolutionizing modern healthcare and emerging as one of the most helpful technologies in today's world. Genomics has shown its ability to prevent, manage, and treat diseases, causing a major shift from conventional treatment methods to precision medicine in the healthcare sector.
Owing to factors like the growing incidence of cancer, growing research and development on genomics, supporting government initiatives, and the declining cost of sequencing, the demand for genomic research companies is on the rise. Also, increased demand for <a href="https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html">personalized medicine</a> and tailored patient care and plans are navigating the market.
Fortune Business Insights forecast the global genomics market to grow from $30.75 billion in 2024 to $80.17 billion by 2032, exhibiting growth at a <a href="https://www.databridgemarketresearch.com/reports/global-genomics-market#:~:text=Genomics%20Market%20Analysis%20and%20Size&amp;text=Data%20Bridge%20Market%20Research%20analyses,period%20of%202023%20to%202030.">CAGR of 12.7%</a>. Essential factors contributing to the market growth include rising genomics applications, growing government support, and implementation of artificial intelligence (AI).
Given the industry's robust outlook, investing in fundamentally strong genomic research stocks A, ILMN, and TXG could be wise.
Let's discuss the fundamentals of these stocks in detail:
Agilent Technologies, Inc. (<a href="https://stocknews.com/stock/A/">A</a>)
A provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets globally. The company operates through three segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab.
On November 14, Agilent announced the innovative Mito-rOCR Assay Kit. Mito-rOCR is an easy and streamlined end-to-end solution that makes sophisticated analysis of mitochondrial function available to researchers of all skill levels with accuracy and ease.
This cost-effective and versatile kit allows researchers to easily incorporate functional assessment of relative mitochondrial respiration into their cell physiology and disease pathology studies.
Also, on October 21, A unveiled its next-generation Agilent InfinityLab LC Series portfolio, consisting of 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions. These are the first HPLC systems featuring the new Agilent InfinityLab Assist Technology, providing enhanced, built-in system assistance capabilities.
This technology elevates lab efficiency with enhanced automation, connectivity, and sustainability capabilities and allows labs to focus more on achieving results rather than on daily operation and maintenance tasks.
During the fourth quarter that ended October 31, 2024, A's <a href="https://www.investopedia.com/terms/r/revenue.asp">net revenue</a> increased 0.8% year-over-year to $1.70 billion, and its income from operations was $408 million. The company's non-GAAP net income and non-GAAP EPS came in at $418 million and $1.46, up 3.5% and 5.8% from the prior-year quarter, respectively.
Additionally, as of October 31, 2024, the company's total assets stood at $11.85 billion compared to $10.76 billion as of October 31, 2023.
According to the company's fiscal first-quarter 2025 outlook, A expects revenue in the range of $1.65 billion to $1.68 billion. Non-GAAP earnings per share are expected to range from $1.25 to $1.28.
Also, for the full year, the company expects revenue between $6.79 billion and $6.87 billion, representing a range of up 4.3% to 5.5% on a reported basis. Also, its non-GAAP earnings are expected to be $5.54 to $5.61 per share.
Analysts expect A's revenue and EPS for the second quarter (ending April 2025) to increase 5.1% and 7% year-over-year to $1.65 billion and $1.31, respectively. Moreover, the company topped the consensus EPS estimates in all four trailing quarters.
Shares of A have surged 5.2% over the past month and 10.5% over the past year to close the last trading session at $138.14.
A's solid fundamentals are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
A has a B grade for Quality. It is ranked #8 out of 41 stocks in the <a href="https://stocknews.com/category/medical-diagnostics-research/">Medical – Diagnostics/Research</a> industry.
In addition to the POWR Ratings we've stated above, we also have A's ratings for Growth, Sentiment, Value, Momentum, and Stability. Get all ratings <a href="https://stocknews.com/stock/A/">here</a>.
Illumina, Inc. (<a href="https://stocknews.com/stock/ILMN/">ILMN</a>)
ILMN offers sequencing- and array-based solutions for genetic and genomic analysis internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, whole-genome sequencing kits, and targeted resequencing kits.
On November 19, ILMN announced that it will release TruSight&#x2122; Oncology 500 v2 (TSO 500 v2) in mid-2025. It is a new version of the company's flagship cancer research assay that enables comprehensive genomic profiling (CGP). The latest solution will enable comprehensive genomic profiling of tumors.
The TSO 500 v2 launch will expand ILMN's TruSight Oncology portfolio with its capability to assess hundreds of genes across all variant classes and immuno-oncology biomarkers in a single assay from one sample to facilitate therapy selection research.
On October 24, ILMN released its MiSeq&#x2122; i100 Series of sequencing systems, offering unparalleled benchtop speed and simplicity to advance next-generation sequencing (NGS) for labs.
During the third quarter that ended September 30, 2024, ILMN reported revenue of $1.08 billion, and its operating profit grew 182.8% from the year-ago value to $741 million. The company's non-GAAP gross profit was $761 million, up 4% from the prior year's quarter.
Furthermore, ILMN's non-GAAP net income and EPS came in at $181 million and $1.14, indicating increases of 248.1% and 245.5% year-over-year, respectively.
For the fourth quarter of 2024, the company raised its guidance for Core Illumina's non-GAAP operating margin to a range of 21% to 21.5%. It expects Core Illumina revenue of $1.07 billion.
For fiscal year 2024, the company's Core Illumina non-GAAP EPS is expected to range from $4.05 to $4.15.
Street expects ILMN's revenue for the first quarter (ending March 2025) to increase marginally year-over-year to $1.08 billion, while its EPS is expected to grow 1015.7% year-over-year to $1, respectively. Furthermore, the company surpassed the consensus revenue estimates in all of the trailing four quarters.
ILMN's stock has gained 37.5% over the past six months and 52.5% over the past year to close the last trading session at $144.36.
ILMN's bright prospects are reflected in its POWR Ratings. The stock has an overall rating of B, equating to a Buy in our proprietary rating system.
The stock has an A grade for Growth. It also has a B grade for Quality. ILMN is ranked #21 among 334 stocks in the <a href="https://stocknews.com/category/biotech/">Biotech</a> industry.
<a href="https://stocknews.com/stock/ILMN/">Click here</a> to access ILMN's ratings for Momentum, Value, Stability, and Sentiment.
10x Genomics, Inc. (<a href="https://stocknews.com/stock/TXG/">TXG</a>)
TXG is a life science technology company that develops and sells instruments, consumables, and software for analyzing biological systems internationally. The company offers chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products.
On October 31, TXG and Cure51, a French TechBio startup, announced that Cure51 will deploy 10x Genomics' Visium HD for its pioneering work to analyze the unique biology of exceptional cancer survivors, whose survival mechanisms could hold the key to new therapeutic approaches.
On October 15, TXG launched two new Chromium products intended to democratize access to single-cell analysis. The company's new offerings, GEM-X Flex and GEM-X Universal Multiplex, introduce significant improvements in performance, workflow, and cost-effectiveness, enabling more researchers to pursue single-cell analysis for more applications.
During the third quarter that ended September 30, 2024, TXG's total consumables revenue increased 10.3% year-over-year to $126.20 million, and its total revenue came in at $151.65 million. The company's gross profit was $106.39 million for the quarter, up 11.4% from the prior year's quarter.
In addition, the company's cash and cash equivalents were $398.16 million as of September 30, 2024, compared to $359.28 million as of December 31, 2023.
The company updated its financial guidance for the full year 2024. The company now expects revenue in the range of $595 million to $605 million.
Street expects TXG's revenue for the first quarter (ending March 2025) to increase 1.2% year-over-year to $142.72 million. For the fiscal year 2025, its revenue is expected to grow 6% year-over-year to $635.36 million.
TXG's stock has declined marginally over the past month to close the last trading session at $15.48.
TXG's POWR Ratings reflect its robust outlook. The stock has a B grade for Value and Quality. Within the <a href="https://stocknews.com/category/medical-services/">Medical - Services</a> industry, TXG is ranked #26 among 63 stocks.
<a href="https://stocknews.com/stock/TXG/">Click here</a> to access additional ratings of TXG for Momentum, Growth, Sentiment, and Stability.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
A shares were trading at $138.04 per share on Friday afternoon, down $0.10 (-0.07%). Year-to-date, A has declined -0.21%, versus a 28.10% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/a-ilmn-txg-3-genomic-research-companies-pioneering-personalized-medicine/>3 Genomic Research Companies Pioneering Personalized Medicine</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Genomic Research Companies Pioneering Personalized Medicine

Worst performing stocks for tax loss selling – Wolfe

10x Genomics wins permanent injunction against NanoString

In an order posted to the site of the U.S. District Court for the District of Delaware, the court stated: "10x Genomics (TXG), Inc. and Prognosys B...

Court grants 10x Genomics' motion in part in patent suit against NanoString

ACHC

ACHR

ACLS

ADPT

AGCO

ALGM

AMKR

AMZN

APLS

ARKF

ARKG

ARKK

ARKQ

ARKW

ARKX

ATKR

AVTR

BCYC

BEAM

BIIB

BMRN

BRBR

BRKR

CERS

CLVT

CNXC

COIN

COLD

CRSP

DINO

DKNG

DXCM

ENPH

EXAS

FIVN

FLNC

HOOD

ILMN

INTC

IONS

IPGP

MCHP

MDXH

MRNA

MYGN

NEOG

NTLA

NTRA

OPCH

PACB

PATH

PINS

PLTR

PRME

PTEN

QDEL

QRVO

RBLX

REGN

REXR

ROKU

RVTY

RXRX

SEDG

SGRY

SHOP

SOFI

STNE

SWKS

SYNA

TSLA

TWST

VCYT

VERV

WOLF

XRAY

Press Releases

10x Genomics Announces Senior Leadership Changes

10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research

Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer

10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting

Earnings

10x Genomics Announces Preliminary Select Third Quarter 2024 Results

10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches

10x Genomics Reports Third Quarter 2024 Financial Results

TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative

10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solns

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Evotec

Fortrea Holdings

Illumina

IQVIA Hldgs

Comments

10x Genomics

Interés en corto

10x Genomics (NASDAQ:TXG) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL